Heart transplant recipients reap significant benefits from a third dose of a COVID-19 vaccine.

The doctor's lawyers argued that these behaviors were a result of his depression and feelings of burnout.

The device has already been approved in other parts of the world, including Europe. 

Researchers examined data from four different studies. The mean patient age was roughly 68 years old. 

The FDA’s decision was based largely on results from a clinical trial that included more than 3,700 heart failure patients with a left ventricular ejection fraction of 40% or less.

Conflicts of interest and undisclosed financial associations may pose a problem for many medical journals.

Repeat TAVR is expected to grow more and more common as time goes on, making it especially important to study its impact on patient outcomes.

Ablation was associated with a 67% reduction in all-cause hospitalizations compared to medication alone. 

The team hopes its findings, published in the European Heart Journal, will help more people consider how their daily lives can affect their health. 

“Our study demonstrates that a centrally guided and well-designed healthcare policy may have a real and substantial impact on a patient’s prognosis over a relatively short period of time,” researchers said.